IRIX Research

Understanding research peptides.

What they are, how they're studied, what “quality” actually means, and where they stand legally in the EU. No claims. No fluff. Just the framework.

01

What is a peptide?

Peptides are short chains of amino acids linked by peptide bonds — the same kind of bond that builds proteins, just shorter. Most research peptides run between 2 and 50 amino acids. Above that length, you're generally talking about a protein instead.

The body already runs on peptides. Insulin (51 amino acids) sits right at the peptide–protein border. Oxytocin (9 amino acids) and glucagon (29 amino acids) are peptides your own body produces constantly. Synthetic research peptides are built the same way in a lab, most commonly through Solid Phase Peptide Synthesis (SPPS) — amino acids added one at a time to a growing chain.

02

How do they work?

Most peptides act as signaling molecules. They bind to a specific receptor on a cell's surface, and that binding event triggers something downstream — a hormone release, a repair pathway, a shift in cell behavior.

BPC-157, for example, is studied for its interaction with the FAK-paxillin pathway, a mechanism tied to cell migration and tissue repair signaling.[1] Semaglutide binds the GLP-1 receptor in both the pancreas and the hypothalamus, which is the basis for its studied effects on insulin secretion and appetite.[2]

Peptides generally have a short half-life in the body and low oral bioavailability, which is why most research protocols use injectable or transdermal delivery rather than oral dosing.

03

Categories of peptides

  • —Approved therapeutic peptides. Cleared by regulators (FDA, EMA) for medical use — insulin, semaglutide, oxytocin, desmopressin. Prescription-only, not what IRIX sells.
  • —Research-grade peptides. Manufactured for laboratory and preclinical research. Not approved for human consumption. This is where IRIX's catalog sits — BPC-157, TB-500, Semax, and the rest.
  • —Cosmetic peptides. Peptides like GHK-Cu appear in dermatology and cosmetic formulations for their studied role in collagen signaling.[3]
  • —Regenerative-research peptides. Studied for tissue repair and wound-healing pathways — BPC-157 and TB-500 (Thymosin β-4) are the most-referenced examples in this category.[4][5]
  • —Metabolic-research peptides. GLP-1 analogs like semaglutide, tirzepatide, and retatrutide, studied for glucose regulation and appetite signaling.[6]
  • —Growth-hormone signaling peptides. Ipamorelin, CJC-1295, and similar compounds, studied for their effect on natural growth hormone secretion.
04

Quality: what HPLC, MS, and a CoA actually mean

Three things determine whether a research peptide is what it claims to be:

  • —HPLC(High-Performance Liquid Chromatography) separates the components in a sample and measures purity. The general industry benchmark is ≥98%.
  • —Mass Spectrometry (MS)confirms the exact molecular weight, verifying the amino acid sequence is correct — not just “mostly right.”
  • —A Certificate of Analysis (CoA) ties HPLC and MS results to a specific batch, identified by a unique LOT number, so a result can be traced back to the exact vial it describes.

This is the standard IRIX's own Certificates Vault is built around — batch-specific, published as results come in, not a generic spec sheet reused across every shipment.

05

Storage and stability

  • —Lyophilized (freeze-dried) peptidesare relatively stable short-term at room temperature, but should be kept refrigerated (2–8°C) or frozen (−20°C) for longer storage.
  • —Reconstituted peptides(mixed with liquid) must be refrigerated and used within roughly 2–4 weeks.
  • —Light and heatdegrade peptide bonds — UV exposure and temperatures above 30°C accelerate breakdown.
  • —Cold-chain shipping— insulated packaging, sometimes with cold packs — matters for maintaining integrity between dispatch and delivery.
06

Legal status in Bulgaria and the EU

Whether a peptide is legal to sell depends entirely on what it's sold as, not the molecule itself.

Research-grade peptides — the category IRIX operates in — are classified as laboratory chemical reagents under EU REACH regulation, not as medicinal products. They're sold for use by qualified researchers and labs, labeled clearly as not for human consumption, and cannot legally be marketed as supplements, cosmetics, or medicines.

Approved therapeutic peptides — semaglutide (Ozempic/Wegovy), tirzepatide(Mounjaro), insulin, and similar EMA-approved drugs — require a prescription in Bulgaria and across the EU. That's a separate legal category entirely from research-grade compounds.

EU Regulatory Note

In December 2025, the EMA adopted a new Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025), effective June 1, 2026.[7] It's worth being precise about what this actually covers: the guideline sets manufacturing and quality-control expectations for synthetic peptides used in medicinal products— it's a drug-development framework, not a regulation of research-use reagents. It doesn't directly govern how IRIX's products are classified or sold. What it does signal is that EU regulators are paying closer attention to peptide manufacturing quality generally, which is part of why independent, batch-specific testing matters more in this category every year, not less.

07

Safety context

Approved peptides (semaglutide, insulin) have well-documented safety profiles from clinical trials — known side effects, known dosing, regulatory oversight. Research-grade peptides don't have that same body of human clinical evidence. Most published reviews on compounds like BPC-157 explicitly call for more human trials before drawing safety conclusions.[8]

This is exactly why the “research use only” framing isn't a legal formality IRIX adds as an afterthought — it reflects where the actual evidence stands.

08

What to look for in a supplier

  • —A Certificate of Analysis for every batch, with real HPLC and MS data
  • —Purity documented at ≥98%
  • —A unique batch/LOT number tied to that specific CoA
  • —Proper storage and cold-chain shipping
  • —A transparent, traceable supply chain — not just a claim of “European manufacturing” with no name attached

This page exists so you don't have to take our word for any of it. Check the Certificates Vault, check the sources below, and decide for yourself.

References
  1. [1]Chang, C.H. et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology.
  2. [2]Alkhouli, M.F. et al. (2025). Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment. Pharmaceuticals (Basel).
  3. [3]Pickart, L. et al. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Research International.
  4. [4]Seiwerth, S. et al. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review. Pharmaceuticals (Basel).
  5. [5]Malinda, K.M. et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology.
  6. [6]Chao, A.M. et al. (2022). Clinical Impact of Semaglutide, a GLP-1 Receptor Agonist, on Obesity Management: A Review. PMC.
  7. [7]European Medicines Agency (2025). Guideline on the Development and Manufacture of Synthetic Peptides. EMA/CHMP/CVMP/QWP/367182/2025. Adopted December 2025, effective June 1, 2026.
  8. [8]Vasireddi, N. et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal.
All IRIX products are intended solely for laboratory research purposes and are not for human or animal consumption. These materials are not intended to diagnose, treat, cure, or prevent any disease. For research use only.